id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-337837-5uynih1y	Nowakowski, Alexandra C H	Brave New Lungs: Aging in the Shadow of COVID-19	2020-08-07		.txt	text/plain	2695	140	50	In the process, it summarizes lessons from established patient populations aging with progressive lung disease—using cystic fibrosis as a prominent example from the author's lived experience—that may enhance the experiences of older COVID-19 survivors. Clinicians and researchers alike can prepare to work with people growing older with COVID-19-induced pulmonary fibrosis by reviewing current knowledge about aging with progressive fibrotic lung pathology secondary to other conditions. Researchers and clinicians focused on aging and old people care should thus consider the promise of different drugs demonstrated to help with the management of chronic pulmonary fibrosis, as well as the appropriateness of using these therapies with people whose lung damage originated with COVID-19 specifically-and how that may differ in patients of older age at onset. More experienced patients whose pulmonary fibrosis originated with other conditions can thus offer valuable support in developing both best clinical practices and responsive community resources for aging and older adults with long-term respiratory impacts from COVID-19.	./cache/cord-337837-5uynih1y.txt	./txt/cord-337837-5uynih1y.txt